Evidence map›Paper›PMID 40143918›Full record

ArticleJHLT open2024

DCD heart transplantation with prolonged functional warm and cold ischemic time using controlled hypothermic preservation: A case report.

Vincenzo Tarzia, Matteo Ponzoni, Marco Gemelli, Nicola Pradegan, Gino Gerosa

Abstract readCase Reports
In one paragraph

Article in JHLT open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vincenzo TarziaCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
Matteo PonzoniCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
Marco GemelliCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
Nicola PradeganCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
Gino GerosaCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the case of successful heart transplantation following donation after circulatory death (DCD) with a prolonged functional ischemic time (43 minutes), which was performed using the Paragonix SherpaPak Cardiac Transport System (SCTS). Due to a mandatory stand-down period of 20 minutes for the confirmation of circulatory death, DCD heart transplantation has so far been considered prohibitive in Italy. Thanks to the very recent implementation of a new national DCD heart protocol, a 24-year-old male with arrhythmogenic right ventricular cardiomyopathy underwent successful heart transplantation with a DCD graft using thoracoabdominal normothermic regional perfusion via femoral vessel cannulation and use of aortic endo-clamp, followed by sternotomy, aortic cross-clamping, and cardioplegia administration in the aortic root. After graft harvesting, SCTS was used for controlled hypothermic preservation during transportation. This case provides novel insights into the myocardial recovery potential following sustained ischemia and highlights the possibility of further expanding the donor's pool using DCD hearts even in countries with prolonged stand-down periods required by law.

Indexed as

DCDheart transplantationSCTSwarm ischemic time

Identifiers

PMID40143918
PMCPMC11935375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.